Diabetic Ketoacidosis Elicits Systemic Inflammation Associated with Cerebrovascular Endothelial Cell Dysfunction

To determine if the DKA‐induced inflammation in juvenile mice provokes activation and dysfunction of CVECs.

[1]  Xin Wei,et al.  Tight Junction in Blood‐Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances , 2012, CNS neuroscience & therapeutics.

[2]  M. Phillipson,et al.  Increased Recruitment but Impaired Function of Leukocytes during Inflammation in Mouse Models of Type 1 and Type 2 Diabetes , 2011, PloS one.

[3]  D. Fraser,et al.  Diabetic Ketoacidosis-Associated Stroke in Children and Youth , 2011, Stroke research and treatment.

[4]  R. Castellani,et al.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis , 2011, Brain Research.

[5]  Ws. Rasband.  ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA , 2011 .

[6]  Jie Fan,et al.  Association of Toll-Like Receptor Signaling and Reactive Oxygen Species: A Potential Therapeutic Target for Posttrauma Acute Lung Injury , 2010, Mediators of inflammation.

[7]  Allan R Brasier,et al.  The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. , 2010, Cardiovascular research.

[8]  R. Veldhuizen,et al.  Mediators released from LPS-challenged lungs induce inflammatory responses in liver vascular endothelial cells and neutrophilic leukocytes. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[9]  S. Amini,et al.  Monocyte chemoattractant protein-1 (MCP-1): an overview. , 2009, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[10]  S. Stamatovic,et al.  Inflammatory mediators and blood brain barrier disruption in fatal brain edema of diabetic ketoacidosis , 2009, Brain Research.

[11]  O. Handa,et al.  Role of endothelial nitric oxide synthase-derived nitric oxide in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis. , 2008, American journal of physiology. Heart and circulatory physiology.

[12]  A. Wong,et al.  Occult infarct with acute hemorrhagic stroke in juvenile diabetic ketoacidosis , 2008, Brain and Development.

[13]  Carol Forsblom,et al.  Acute hyperglycaemia induces an inflammatory response in young patients with type 1 diabetes , 2008, Annals of medicine.

[14]  T. Kossmann,et al.  Modulation of immune response by head injury. , 2007, Injury.

[15]  D. Ramsay,et al.  Coma With Diffuse White Matter Hemorrhages in Juvenile Diabetic Ketoacidosis , 2007, Pediatrics.

[16]  Sushil K. Jain,et al.  High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes. , 2007, Antioxidants & redox signaling.

[17]  M. Cybulsky,et al.  Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.

[18]  M. Casanova,et al.  Neuroinflammatory response of the choroid plexus epithelium in fatal diabetic ketoacidosis. , 2007, Experimental and molecular pathology.

[19]  D. Fraser,et al.  Combined Insulin and Bicarbonate Therapy Elicits Cerebral Edema in a Juvenile Mouse Model of Diabetic Ketoacidosis , 2007, Pediatric Research.

[20]  S. Jander,et al.  T-cell cytokines in injury-induced neural damage and repair , 2007, NeuroMolecular Medicine.

[21]  C. Förster,et al.  Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli , 2006, Journal of Neuroimmunology.

[22]  J. Haorah,et al.  Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions , 2006, Journal of Neuroimmune Pharmacology.

[23]  C. Cudrici,et al.  Complement activation in diabetic ketoacidosis brains. , 2006, Experimental and molecular pathology.

[24]  Anne V. Herdman,et al.  Diabetic ketoacidosis increases extracellular levels of the major inducible 70-kDa heat shock protein. , 2005, Clinical Biochemistry.

[25]  C. Burek,et al.  Complement activation in diabetic ketoacidosis and its treatment. , 2005, Clinical immunology.

[26]  J. Allison,et al.  Study of Subclinical Cerebral Edema in Diabetic Ketoacidosis by Magnetic Resonance Imaging T2 Relaxometry and Apparent Diffusion Coefficient Maps , 2005, Endocrine research.

[27]  M. Buonocore,et al.  Mechanism of cerebral edema in children with diabetic ketoacidosis. , 2004, The Journal of pediatrics.

[28]  T. Tulassay,et al.  Urinary prostaglandins in hyperglycaemic ketoacidosis of type I diabetes mellitus , 2004, Pediatric Nephrology.

[29]  R. Dalton,et al.  Plasma C-reactive protein levels in severe diabetic ketoacidosis. , 2003, Annals of clinical and laboratory science.

[30]  J. Bocchini,et al.  Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. , 2003, Diabetes care.

[31]  Helga E de Vries,et al.  The Blood‐Brain Barrier and Its Role in Immune Privilege in the Central Nervous System , 2003, Journal of neuropathology and experimental neurology.

[32]  J. Chiasson,et al.  Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[33]  K. Motoyoshi,et al.  Interleukin‐10 differently regulates monocyte chemoattractant protein‐1 gene expression depending on the environment in a human monoblastic cell line, UG3 , 2002, Journal of leukocyte biology.

[34]  L. Kappelle,et al.  Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease , 2002, Stroke.

[35]  D. Sredni-Kenigsbuch.  TH1/TH2 CYTOKINES IN THE CENTRAL NERVOUS SYSTEM , 2002, The International journal of neuroscience.

[36]  Inder M Verma,et al.  NF-kappaB regulation in the immune system. , 2002, Nature reviews. Immunology.

[37]  W. Hoffman,et al.  Acute activation of peripheral lymphocytes during treatment of diabetic ketoacidosis. , 2001, Journal of diabetes and its complications.

[38]  J. Szelényi.  Cytokines and the central nervous system , 2001, Brain Research Bulletin.

[39]  A. Rosenbloom.  Prevention of Type 1 Diabetes: Perspectives , 2000 .

[40]  J. Krischer,et al.  Therapeutic controversy: prevention and treatment of diabetes in children. , 2000, The Journal of clinical endocrinology and metabolism.

[41]  K. Satoh,et al.  Inflammatory Mediators of Cerebral Endothelium: A Role in Ischemic Brain Inflammation , 2000, Brain pathology.

[42]  L. Laffel.  Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes , 1999, Diabetes/metabolism research and reviews.

[43]  B. Delpech,et al.  Hyaluronectin secretion by monocytes: downregulation by IL-4 and IL-13, upregulation by IL-10. , 1999, Cytokine.

[44]  C. Isales,et al.  Acetoacetate and β-Hydroxybutyrate Differentially Regulate Endothelin-1 and Vascular Endothelial Growth Factor in Mouse Brain Microvascular Endothelial Cells , 1999 .

[45]  C. Isales,et al.  Acetoacetate and beta-hydroxybutyrate differentially regulate endothelin-1 and vascular endothelial growth factor in mouse brain microvascular endothelial cells. , 1999, Journal of diabetes and its complications.

[46]  S. Jain,et al.  Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. , 1998, Free radical biology & medicine.

[47]  T. Crawford,et al.  Brain infarction in children with diabetic ketoacidosis. , 1996, Journal of diabetes and its complications.

[48]  W. Raub.  From the National Institutes of Health. , 1990, JAMA.

[49]  C. Steinhart,et al.  Cranial CT in children and adolescents with diabetic ketoacidosis. , 1988, AJNR. American journal of neuroradiology.